Intuitive Surgical, Inc. $ISRG is Lattice Capital Management LLC's 8th Largest Position

Key Points

• Lattice Capital Management cut its Intuitive Surgical stake by 44% in Q4 to 5,600 shares, making ISRG its 8th-largest holding (4.4% of the portfolio) valued at about $3.17 million.
• Intuitive topped expectations for the quarter with $2.50 EPS vs. $2.08 consensus and revenue of $2.77 billion, a 23% year-over-year increase.
• Analysts hold a consensus rating of Moderate Buy with an average target price of $581.91, based on 18 Buys, 7 Holds and 1 Sell.

Lattice Capital Management LLC lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 44.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,600 shares of the medical equipment provider's stock after selling 4,400 shares during the quarter. Intuitive Surgical comprises 4.4% of Lattice Capital Management LLC's portfolio, making the stock its 8th biggest holding. Lattice Capital Management LLC's holdings in Intuitive Surgical were worth $3,172,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Holos Integrated Wealth LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $25,000. Newbridge Financial Services Group Inc. boosted its holdings in shares of Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 33 shares during the period. Greykasell Wealth Strategies Inc. purchased a new position in shares of Intuitive Surgical in the 3rd quarter worth approximately $27,000. Olistico Wealth LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $28,000. Finally, Caitlin John LLC purchased a new position in shares of Intuitive Surgical in the 3rd quarter worth approximately $30,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent research reports. Barclays set a $651.00 target price on Intuitive Surgical and gave the stock an "overweight" rating in a report on Thursday, April 23rd. JPMorgan Chase & Co. dropped their target price on Intuitive Surgical from $625.00 to $550.00 and set an "overweight" rating for the company in a report on Wednesday, April 22nd. HSBC dropped their price objective on Intuitive Surgical from $653.00 to $604.00 and set a "buy" rating for the company in a report on Wednesday, April 22nd. Robert W. Baird boosted their price objective on Intuitive Surgical from $575.00 to $610.00 and gave the company an "outperform" rating in a report on Wednesday, April 22nd. Finally, Leerink Partners dropped their price objective on Intuitive Surgical from $622.00 to $573.00 and set an "outperform" rating for the company in a report on Wednesday, April 22nd. Eighteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $581.91.

Insiders Place Their Bets

In other news, VP Fredrik Widman sold 133 shares of the business's stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $65,829.68. Following the completion of the transaction, the vice president directly owned 660 shares of the company's stock, valued at approximately $326,673.60. The trade was a 16.77% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Amy L. Ladd sold 119 shares of the business's stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total value of $55,156.50. Following the completion of the transaction, the director directly owned 120 shares of the company's stock, valued at approximately $55,620. The trade was a 49.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 5,906 shares of company stock worth $2,907,726. 0.60% of the stock is owned by company insiders.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $457.78 on Monday. Intuitive Surgical, Inc. has a twelve month low of $427.84 and a twelve month high of $603.88. The stock has a market capitalization of $162.13 billion, a price-to-earnings ratio of 55.49, a P/E/G ratio of 3.66 and a beta of 1.51. The stock has a fifty day simple moving average of $474.86 and a two-hundred day simple moving average of $517.11.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The business had revenue of $2.77 billion during the quarter, compared to analysts' expectations of $2.62 billion. During the same period in the prior year, the business earned $1.81 EPS. The business's revenue for the quarter was up 23.0% compared to the same quarter last year. Research analysts predict that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.